Heparin in the Initial Treatment of Venous Thrombosis
- 20 September 1990
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (12) , 830-831
- https://doi.org/10.1056/nejm199009203231213
Abstract
A demonstration of the effectiveness of shorter therapy for deep venous thrombosis has been eagerly awaited at all levels of the cost-aware health care system. The study by Hull and colleagues (May 3 issue)* provides some affirmative evidence but should not be regarded as sufficient to recommend widespread changes in the standard of care.Keywords
This publication has 11 references indexed in Scilit:
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Guidelines for Statistical Reporting in Articles for Medical JournalsAnnals of Internal Medicine, 1988
- SAFETY AND EFFICACY OF WARFARIN STARTED EARLY AFTER SUBMASSIVE VENOUS THROMBOSIS OR PULMONARY EMBOLISMThe Lancet, 1986
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- When was a "negative" clinical trial big enough? How many patients you needed depends on what you foundArchives of internal medicine (1960), 1985
- Heparin-Associated ThrombocytopeniaAnnals of Internal Medicine, 1984
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Thrombocytopenia Occurring During the Administration of HeparinAnnals of Internal Medicine, 1976
- Studies on Coumarin Anticoagulant DrugsCirculation, 1968
- Evidence for an antithrombotic effect of DicumarolAmerican Journal of Physiology-Legacy Content, 1960